Business ❯Pharmaceuticals

Vaccine Development

Novavax Market Reactions AstraZeneca COVID-19 Vaccine mRNA Technology Investment Decisions Cancer Vaccine Covid-19 Vaccines Research and Development Seattle-based Pfizer Moderna Market Impact

Vaxart's Oral Norovirus Vaccine Shows Promise in Early Trials for Elderly Adults

Phase 1b trial data reveals strong immune responses, reduced viral shedding, and potential for broader applications in combating viral diseases.

Moderna Wins Patent Case Against BioNTech and Pfizer Over mRNA Technology

Scientists Identify New Coronavirus in Bats Capable of Infecting Humans

AstraZeneca Cancels £450m UK Vaccine Plant Investment

BioNTech Settles COVID-19 Vaccine Royalty Disputes for $1.2 Billion

FDA Authorizes New Novavax Vaccine Targeting Omicron Variant

AstraZeneca's £450m UK Vaccine Plant Faces Funding Uncertainty

Pfizer Seeks FDA Approval for RSV Vaccine in Young Adults